Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Biography

Meet the Editorial Board Member

Author(s): Jamshed Iqbal

Volume 30, Issue 27, 2023

Published on: 27 March, 2023

Page: [3051 - 3051] Pages: 1

DOI: 10.2174/092986733027230327131034

conference banner
Next »
[1]
Imran, A.; Shehzad, M.T.; Shah, S.J.A.; Al Adhami, T.; Laws, M.; Rahman, K.M.; Alharthy, R.D.; Khan, I.A.; Shafiq, Z.; Iqbal, J. Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study. Sci. Rep., 2022, 12, 1-14.
[2]
Mahmood, A.; Villinger, A.; Iqbal, J. Therapeutic potentials and structure-activity relationship of 1, 3-benzodioxole N-carbamothioyl carboxamide derivatives as selective and potent antagonists of P2X4 and P2X7 receptors. Eur. J. Med. Chem., 2022, 114491.
[3]
Imran, A.; Shehzad, M.T.; Shah, S.J.A.; Laws, M.; Al-Adhami, T.; Rahman, K.M.; Khan, I.A.; Shafiq, Z.; Iqbal, J. Development, Molecular Docking, and In Silico ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications via Suppression of the Polyol Pathway. ACS Omega, 2022, 7, 26425-26436.
[4]
Ullah, S.; Pelletier, J.; Sévigny, J.; Iqbal, J. Synthesis and Biological Evaluation of Arylamide Sulphonate Derivatives as Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 and-3 Inhibitors. ACS Omega, 2022, 7, 26905-26918.
[5]
Mahmood, A.; Iqbal, J. Purinergic Receptors Modulators: An Emerging Pharmacological Tool for Disease Management. Med. Res. Rev., 2022, 42, 1661-1703.

© 2024 Bentham Science Publishers | Privacy Policy